GLP-1s could cause beer sales to take a hit, report says
Summary
A report says GLP-1 drugs could hurt beer sales. It says Heineken advised customers to offer half-pints and low- or no-alcohol options.Key Facts
- The report links GLP-1 drugs to a possible decline in beer sales.
- The article attributes the potential sales impact to a report.
- Heineken advised its customers to pursue half-pints.
- Heineken advised its customers to pursue low-alcohol options.
- Heineken advised its customers to pursue no-alcohol options.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
